Phase II study with cisplatin and paclitaxel in combination with weekly high-dose 24 h infusional 5-fluorouracil/leucovorin for first-line treatment of metastatic breast cancer
1998 ◽
Vol 9
(3)
◽
pp. 203-208
◽
Keyword(s):
Phase Ii
◽